Journal Publications

Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.

Article Title Journal
Prediction of Overall Survival for Metastic Pancreatic Cancer: Development and Validation of a Prognostic Nomogram with Data from Open Clinical Trial and Real-World Study Cancer Medicine
Prediction of Overall Survival for Patients with Metastatic Castration-Resistant Prostate Cancer: Development of a Prognostic Model Through a Crowdsourced Challenge with Open Clinical Trial Data The Lancet Oncology
Reference values for the EORTC QLQ-C30 in early and metastatic breast cancer European Journal of Cancer
Treatment Stratification of Patients with Metastatic Castration-Resistant Prostate Cancer by Machine Learning iScience
The Prostate Cancer DREAM Challenge: A Community-Wide Effort to Use Open Clinical Trial Data for the Quantitative Prediction of Outcomes in Metastatic Prostate Cancer The Oncologist
Project Data Sphere to Make Cancer Clinical Trial Data Publicly Available Journal of the National Cancer Institute
Evaluating predictors of renal injury with sorafenib in hepatocellular carcinoma: A multi-ethnic cohort study Journal of Onco-Nephrology
Matrix decomposition in meta‐analysis for extraction of adverse event pattern and patient‐level safety profile Pharmaceutical Statistics
The application of electronic medical records (EMRs) as a virtual comparator arm in a lung cancer clinical trial: A case study Journal of Clinical Oncology
Optimizing the synthesis of clinical trial data using sequential trees Journal of the American Medical Informatics Association
A workflow for the joint modeling of longitudinal and event data in the development of therapeutics: Tools, statistical methods, and diagnostics ASCPT
Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma American Association for Cancer Research
Drug resistant cells with very large proliferative potential grow exponentially in metastatic prostate cancer Oncotarget
Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2-) breast cancer prior to chemo-endocrine therapy Annals of Oncology

Pages